RAB39B: A novel biomarker for acute myeloid leukemia identified via multi-omics and functional validation.

Open Med (Wars) · 2025 · PMC11964188 · PMID 40177653

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

showed a trendP = 0.072so close (0.05 < p ≤ 0.1)

Additionally, high RAB39B expression was correlated with higher BM blast counts ( P = 0.012) and showed a trend toward correlation with higher peripheral blood (PB) blast counts ( P = 0.072) and white blood cell (WBC) counts ( P = 0.060).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.